PAR
Click for more information
0.00% 22.5¢ paradigm biopharmaceuticals limited..

re Epiitalissee Clinicaltrials.govthe trial was listed but NOT...

  1. Wwend
    74 Posts.
    lightbulb Created with Sketch. 11
    clock Created with Sketch.
    23/07/21
    06:50
    Post #: 54708308
    re Epiitalis

    see Clinicaltrials.gov
    the trial was listed but NOT evaluated by the FDA
    the sponsor is Vedic Life Sciences.
    the trials were done in nursing homes in Mumbai India.
    PAR Price at posting: $2.01 Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

3DA To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels
right-arrow Created with Sketch.
NEWS Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
right-arrow Created with Sketch.
NEWS HotCopper Highlights: Your most watched and most discussed stocks this week
right-arrow Created with Sketch.
NEWS Imugene kicks off Australian trial for blood cancer treatment
right-arrow Created with Sketch.
NEWS Update on the ASX' most anticipated drill campaign
right-arrow Created with Sketch.
EQN Equinox Resources reports outstanding naturally occurring antimony grade at Alturas Project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $78.73M
Open High Low Value Volume
23.0¢ 23.0¢ 21.5¢ $78.13K 350.8K

Buyers (Bids)

No. Vol. Price($)
2 64880 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
22.5¢ 43479 1
View Market Depth
Last trade - 16.10pm 11/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.